The following video is from Thursday's Investor Beat, in which host Rex Moore, and analysts Jason Moser and Matt Koppenheffer dissect the hardest-hitting investing stories of the day.
The market saw continued volatility today as those crazy traders are still worried about the Fed's signals that it might ease back on its bond-buying program that's helped the recovery.
In this installment of Investor Beat, Motley Fool analysts Jason Moser and Matt Koppenheffer question whether investors should really be worrying, and which stocks look attractive for the long term.
Now more than ever, it's essential to take control of your investments if you want to have a financially secure retirement. The Fool wants to help you retire rich, so we've put together a research report with three promising stocks specifically chosen with long-term retirement investors in mind. Don't miss out on this absolutely free report; click here and get your copy today!�
Best Specialty Retail Stocks To Own For 2015: Natus Medical Incorporated(BABY)
Natus Medical Incorporated provides neurodiagnostic and newborn care products worldwide. The company offers healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Its product offerings include neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn?s environment; and software systems for managing and tracking disorders and diseases. The company provides newborn hearing screening product lines consisting of the ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hea ring screening devices. It also offers diagnostic hearing assessment product lines, which include the Navigator Pro system, the Scout sport portable diagnostic device, and the AuDX PRO; and diagnostic hearing supply products. In addition, the company provides monitoring systems, balance and mobility products, newborn brain injury diagnostic products, thermoregulation products, and jaundice management products. Further, it offers photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, restraining boards, and newborn circumstraints; neonatal noise attenuators, phototherapy eye masks, and x-ray shields for reproductive organs; and newborn screening data management products. The company serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in San Carlos, California.
Advisors' Opinion:- [By Sean Williams]
We could always blame Europe for the shortfall; I mean everyone else is doing it, right? Just yesterday, niche diagnostic and device maker for infants and newborns Natus Medical (NASDAQ: BABY ) warned that its revenue would be short of the Street's estimates because of tepid European demand for its products. Even having products with little competition in a niche category (infants and newborns) wasn't enough to save Natus Medical; could that be the reason Intuitive is faltering?
Hot Promising Stocks To Own Right Now: TotalFinaElf S.A.(TOT)
TOTAL S.A., together with its subsidiaries, operates as an integrated oil and gas company worldwide. The company operates through three segments: Upstream, Downstream, and Chemicals. The Upstream segment engages in the exploration, development, and production of oil and natural gas. It also involves in the transportation, trade, and marketing of natural gas and liquefied natural gas (LNG), as well as in LNG re-gasification and natural gas storage operations. In addition, this segment engages in the shipping and trade of liquefied petroleum gas (LPG); power generation from gas-fired power plants, nuclear, or renewable energies; production, trade, and marketing of coal, as well as in solar power systems and technology operations. As of December 31, 2010, it had combined proved reserves of 10,695 Mboe of oil and gas. The Downstream segment involves in refining, marketing, trading, and shipping crude oil and petroleum products. It also produces a range of specialty products, s uch as lubricants, LPG, jet fuel, special fluids, bitumen, marine fuels, and petrochemical feedstock. This segment holds interests in 24 refineries located in Europe, the United States, the French West Indies, Africa, and China, as well as operates a network of 17,490 service stations. The Chemicals segment produces base chemicals, including petrochemicals and fertilizers, as well as engages in rubber processing, resins, adhesives, and electroplating activities. TOTAL S.A. was founded in 1924 and is based in Paris, France.
Advisors' Opinion:- [By Travis Hoium]
ABB (NYSE: ABB ) is spending $1 billion to buy Power-One (NASDAQ: PWER.DL ) , a major player in solar inverters. This is the latest move by a large energy company to buy into solar following Total (NYSE: TOT ) and General Electric (NYSE: GE ) . Will we see more solar buyouts? Erin Miller sat down with Fool contributor Travis Hoium to find out.�
- [By Associated Press]
ALEXANDRIA, Va. (AP) -- The French oil giant Total� (NYSE: TOT ) has agreed to pay $242.5 million to settle criminal charges alleging the company paid bribes to win lucrative contracts in Iran.
- [By Sara Sjolin]
Shares of oil giant Total SA (FR:FP) � (TOT) �dropped 1.3%.
Hot Promising Stocks To Own Right Now: Five Star Quality Care Inc (FVE)
Five Star Quality Care, Inc. (Five Star), incorporated in April 2000, operates senior living communities, including independent living communities, assisted living communities and skilled nursing facilities (SNFs). As of December 31, 2011, the Company operated 245 senior living communities located in 30 states containing 27,159 living units, including 207 primarily independent and assisted living communities with 23,736 living units and 38 SNFs with 3,423 living units. The Company owns and operates 31 communities (2,954 living units), lease and operate 191 communities (20,811 living units), and manage 23 communities (3,394 living units). Its 245 senior living communities included 8,699 independent living apartments, 13,069 assisted living suites and 5,391 skilled nursing units. During the year ended December 31, 2011, the Company discontinued its operations on two SNFs owned and operated by it containing 271 living units and one assisted living community leased from Senior Housing Properties Trust (SNH) and operated by it containing 103 living units. In September 2012, it sold its pharmacy business to Omnicare, Inc. Effective December 31, 2013, Five Star transferred the operations of two rehabilitation hospitals, which included New England Rehabilitation Hospital located in Woburn and Braintree Rehabilitation Hospital located in Braintree, to entities affiliated with Reliant Hospital Partners, LLC.
As of December 31, 2011, the Company leased and operated two rehabilitation hospitals with 321 beds that provide inpatient rehabilitation services to patients at the two hospitals and at three satellite locations. In addition, it leased and operated 13 outpatient clinics affiliated with these rehabilitation hospitals. It also owns and operate five institutional pharmacies. In 2011, the Company acquired from unrelated parties seven assisted living communities containing 854 living units with one located in Arizona and the other six located in Indiana, or the Indiana Communities. It also commenc! ed leasing from SNH six senior living communities containing 724 living units with one located in each of Illinois and Florida and two located in each of North Carolina and Virginia.
Independent Living Communities
Independent living communities provide privacy to residents and require residents to be capable of independence. An independent living apartment usually bundles several services as part of a regular monthly charge. In addition, services are available from staff employees on a fee for service basis. As of December 31, 2011, its business included 8,699 independent living apartments in 75 communities that it operated or managed.
Assisted Living Communities
Assisted living communities consists of one bedroom units which include private bathrooms and kitchens. Services bundled within one charge usually include three meals per day in a central dining room, daily housekeeping, laundry, medical reminders and around the clock availability of assistance with the activities of daily living such as dressing and bathing. Professional nursing and healthcare services are usually available at the community as requested or at regularly scheduled times. As of December 31, 2011, its business included 13,069 assisted living suites in 185 communities that it operated or managed. .
Skilled Nursing Facilities
SNFs provide nursing and healthcare services similar to those available in hospitals. A purpose built SNF includes one or two beds per room with a separate bathroom in each room and shared dining facilities. SNFs are staffed by licensed nursing professionals 24 hours per day. As of December 31, 2011, its business included 5,391 skilled nursing units in 69 communities.
Rehabilitation Hospitals
Rehabilitation hospitals, which are also known as inpatient rehabilitation facilities (IRFs), provide intensive physical therapy, occupational therapy and speech language pathology services. Patients in IRFs receive a mi! nimum of ! three hours of rehabilitation services daily. IRFs also provides radiology, laboratory, telemetry, hemodialysis and orthotics/prosthetics services. Outpatient satellite clinics are often included as part of the services offered by IRFs. As of December 31, 2011, its two rehabilitation hospitals had 321 beds available for inpatient services and provided rehabilitation services at the two hospitals and three satellite locations. In addition, it operates 13 outpatient clinics affiliated with its rehabilitation hospitals where patients discharged from hospitals can continue their therapy programs and receive amputee, brain injury, neurorehabilitation, cardio-pulmonary, orthopedic, spinal cord injury and stroke rehabilitation services.
Institutional Pharmacies
Institutional pharmacies provide drugs at locations where patients with recurring pharmacy requirements are concentrated. The Company�� five institutional pharmacies are located in six leased commercial spaces and one owned commercial building containing a total of approximately 67,759 square feet plus parking areas for its employees and delivery vehicles.
Advisors' Opinion:- [By Laura Brodbeck]
Tuesday
Earnings Expected From: Five Star Quality Care, Inc. (NYSE: FVE), Maximus, Inc. (NYSE: MMS), Nustar Energy (NYSE: NS), D.R. Horton, Inc. (NYSE: DHI), DISH Network Corporation (NASDAQ: DISH) Economic Releases Expected: German CPI, British CPI, British PPI, US Redbook, Indian manufacturing output, Indian industrial productionWednesday
- [By Keith Speights]
Falling stars
The sky didn't fall, but it might have seemed like it this week for shareholders of Five Star Quality (NYSE: FVE ) . The stock dropped 21% after the operator of long-term-care facilities reported quarterly earnings.
Hot Promising Stocks To Own Right Now: Principal Financial Group Inc(PFG)
Principal Financial Group, Inc. provides retirement savings, investment, and insurance products and services worldwide. The company?s Retirement and Investor Services segment provides retirement savings and related investment products and services, including a portfolio of asset accumulation products and services primarily to small and medium-sized businesses and individuals in the United States. This segment offers products and services to businesses for defined contribution pension plans, including 401(k) and 403(b) plans, defined benefit pension plans, nonqualified executive benefit plans, and employee stock ownership plan consulting services; and annuities, mutual funds, and bank products and services to the employees of its business customers and other individuals. Principal Financial Group?s Principal Global Investors segment offers a range of equity, fixed income, and real estate investments, as well as specialized overlay and advisory services to institutional inve stors. The company?s Principal International segment offers retirement products and services, annuities, mutual funds, institutional asset management, and life insurance accumulation products in Brazil, Chile, China, Hong Kong SAR, India, Indonesia, Malaysia, Mexico, Singapore, and Thailand. Principal Financial Group?s U.S. Insurance Solutions segment offers individual life insurance, as well as specialty benefits in the United States. Its individual life insurance products include universal and variable universal life insurance and traditional life insurance; and specialty benefit products comprise group dental and vision insurance, individual and group disability insurance, and group life insurance, as well as fee-for-service claims administration and wellness services. The company was founded in 1879 and is based in Des Moines, Iowa.
Advisors' Opinion:- [By Patricio Kehoe] ts newest deal with private benefits company Liazon Corp., through which the firm will offer employer-sponsored group benefit plans to small and medium businesses. While the company already sells ancillary benefit plans, this deal will now also include dental, life insurance, disability insurance and critical illness coverage in an attempt to stay on top of the insurance industry. As an industry leader, Principal has over $466 billion in assets under management and 19 million customers, fragmented among small and medium-size businesses. Furthermore, its solid fourth quarter results have encouraged investment gurus like Paul Tudor Jones (Trades, Portfolio) and Steven Cohen (Trades, Portfolio) to recently acquire large amounts of the company�� shares. So, let�� see what this insurer has in store for the future.
Broadening Horizons
Although Principal�� core business is in life insurance, the company has been pursuing a more diverse growth strategy lately, and is now focused on expanding its position in the retirement service and asset management segment. With almost 30,700 pension plans covering over 3.4 million customers, this business��growth rate has not only boosted overall profitability, marked by a 31% annual increase in operating earnings for fiscal 2013, but also helped offset the headwinds of low interest rates and volatility in the emerging markets. In fact, the fourth quarter showed a 65% boost in premium and fee income for the segmenta , consequence of the rollout of total retirement suite products.
Moreover, Principal�� emphasis on retirement products and its use of capital salesforce for distribution has added on to the natural switching cost advantage in the insurance industry. Since plan sponsors provided with pension assets rarely switch providers, the company will likely benefit in the long term from its persistency, as seen in the quarterly 9% bump in recurring deposits.
On another note, Principal�� fee-based b
- [By Michael Calia]
Principal Financial Group Inc.(PFG) said its fourth-quarter earnings rose 8.6%, touting its strong results for the period amid continued economic concern.
Hot Promising Stocks To Own Right Now: Agenus Inc.(AGEN)
Agenus Inc., a biotechnology company, engages in developing and commercializing technologies to treat cancers and infectious diseases. It offers Oncophage vaccine for the treatment of adjuvant renal cell carcinoma. The company?s products under development include Prophage series of cancer vaccines, which has been tested in Phase III clinical trials for the treatment of renal cell carcinoma (RCC) and metastatic melanoma, as well as has been tested in Phase I and Phase II clinical trials in various indications; and under Phase II clinical trials in glioma, a type of brain cancer, and adjuvant renal cell carcinoma. The Prophage series of cancer vaccines include R-series candidates in RCC, M-series candidates in melanoma, and G-series candidates in glioma. Its product candidate portfolio includes QS-21 Stimulon adjuvant, which is in Phase III clinical trials for the treatment of non-small cell lung cancer, melanoma, malaria, and shingles, as well as in for the treatment of va rious infectious diseases and Alzheimer?s disease; and HerpV that completed Phase 1 clinical trial for the treatment of genital herpes. The company was formerly known as Antigenics Inc. and changed its name Agenus Inc. in January 2011 to reflect its existing product pipeline. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
Advisors' Opinion:- [By Garrett Cook]
Agenus Inc. (NASDAQ: AGEN) shares shot up 32.12 percent to $5.43 after the company announced a partnership with Incyte.
Shares of Infosys Ltd. (NYSE: INFY) got a boost, shooting up 4.39 percent to $33.52 after the company reported higher net profit for the three months ended Dec. 31. The company also maintained its revenue growth forecast for the year.
- [By Monica Gerson]
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Most Popular Are Massive Xbox One 'Titanfall' Sales To Blame For Xbox 360 Game Delay? Warren Buffett's Conflicting Bitcoin Views Marijuana Econom - [By John Udovich] Follow-on Stock Offerings From Small Cap Biotech Stocks. Thanks to the boom in biotech IPOs along with the sector�� overall performance, already listed biotechs have the option to ask investors for more cash in the form of a follow-on offering. Recently, FierceBiotech.com noted how four small cap biotechs raised $276 million from follow-on offerings in just one day last week. These small caps�included Epizyme Inc (NASDAQ: EPZM) which raised $88 million, Halozyme Therapeutics, Inc (NASDAQ: HALO) which raised $100 million, Agenus Inc (NASDAQ: AGEN) which raised $52 million and Idera Pharmaceuticals Inc (NASDAQ: IDRA) which raised $36 million. FierceBiotech.com noted that the�steady flow of about $4.5 billion a year in venture cash�along with�more than $3.5 billion from IPOs last year plus all of the�follow-ons are helping to foster both company growth and�accelerate drug�development programs. Mixed Bag for Biotech IPOs. Last Wednesday also saw two small cap biotech IPOs fizzle in one day�with small cap T cell vaccine developer�Genocea Biosciences Inc (NASDAQ: GNCA) raising $60 million but then ending the day down 8.3% to close at $11 while Dutch drug developer uniQure NV (QURE) raised $81.9 million but fell more than 14% to $14.61. However, orphan drug stock Auspex Pharmaceuticals Inc (NASDAQ: ASPX), which is developing�drugs to treat orphan diseases like Tourette syndrome, saw a 30.5% gain to close at $15.66 and raise $84 million. The Boston Globe quoted Michael Ringel, a partner and managing director at Boston Consulting Group who focuses on health care business, as saying:
��he mood is incredibly positive. Capital is flowing. [The biotech IPOs]��have been burning hot. I think it�� too early to suggest that is changing. I can�� predict the overall economy any better than anyone else, but I would expect a pretty good year for IPOs.��/p>
No comments:
Post a Comment